Jane E Ewing1, Madeleine T King, Narelle F Smith. 1. Department of Mathematical Sciences, Faculty of Science, University of Technology, Sydney (UTS), P.O. Box 123, Broadway, Sydney, NSW, Australia. jane.ewing@uts.edu.au
Abstract
PURPOSE: To validate two health-related quality of life (HRQOL) measures, the PedsQL Generic Core and Cancer Module adolescent forms (13-18 years), after modification for 16-25-year-old adolescents and young adults (AYA) with cancer or a blood disorder. METHODS: AYA patients and nominated proxies were recruited from three Sydney hospitals. Modified forms were administered by telephone or in clinics/wards. Analyses included correlations, factor analysis, and analysis of variance of known-groups (defined by the Memorial Symptom Assessment Scale). RESULTS: Eighty-eight patients and 79 proxies completed questionnaires. Factor structures consistent with those of the unmodified forms confirmed construct validity. Cronbach's alpha ranged 0.81-0.98. Inter-scale correlations were as hypothesized, confirming discriminant validity. Statistically significant differences between groups with mild, moderate, and severe symptoms (P < 0.05) confirmed clinical validity. CONCLUSION: These modified forms provide reliable and valid measures of HRQOL in AYA with cancer or a blood disorder, suitable for clinical trials, research, and practice.
PURPOSE: To validate two health-related quality of life (HRQOL) measures, the PedsQL Generic Core and Cancer Module adolescent forms (13-18 years), after modification for 16-25-year-old adolescents and young adults (AYA) with cancer or a blood disorder. METHODS: AYA patients and nominated proxies were recruited from three Sydney hospitals. Modified forms were administered by telephone or in clinics/wards. Analyses included correlations, factor analysis, and analysis of variance of known-groups (defined by the Memorial Symptom Assessment Scale). RESULTS: Eighty-eight patients and 79 proxies completed questionnaires. Factor structures consistent with those of the unmodified forms confirmed construct validity. Cronbach's alpha ranged 0.81-0.98. Inter-scale correlations were as hypothesized, confirming discriminant validity. Statistically significant differences between groups with mild, moderate, and severe symptoms (P < 0.05) confirmed clinical validity. CONCLUSION: These modified forms provide reliable and valid measures of HRQOL in AYA with cancer or a blood disorder, suitable for clinical trials, research, and practice.
Authors: John J Collins; Tom D Devine; Gina S Dick; Elizabeth A Johnson; Henry A Kilham; C Ross Pinkerton; M M Stevens; Howard T Thaler; Russell K Portenoy Journal: J Pain Symptom Manage Date: 2002-01 Impact factor: 3.612
Authors: J J Collins; M E Byrnes; I J Dunkel; J Lapin; T Nadel; H T Thaler; T Polyak; B Rapkin; R K Portenoy Journal: J Pain Symptom Manage Date: 2000-05 Impact factor: 3.612
Authors: D F Cella; D S Tulsky; G Gray; B Sarafian; E Linn; A Bonomi; M Silberman; S B Yellen; P Winicour; J Brannon Journal: J Clin Oncol Date: 1993-03 Impact factor: 44.544
Authors: Anne E Mitchell; Deborah L Scarcella; Gemma L Rigutto; Vicky J Thursfield; Graham G Giles; Maree Sexton; David M Ashley Journal: Med J Aust Date: 2004-01-19 Impact factor: 7.738
Authors: Rhonda S Robert; Raheem J Paxton; Shana L Palla; Grace Yang; Martha A Askins; Shaini E Joy; Joann L Ater Journal: Pediatr Blood Cancer Date: 2012-02-02 Impact factor: 3.167
Authors: Ashley Wilder Smith; Keith M Bellizzi; Theresa H M Keegan; Brad Zebrack; Vivien W Chen; Anne Victoria Neale; Ann S Hamilton; Margarett Shnorhavorian; Charles F Lynch Journal: J Clin Oncol Date: 2013-05-06 Impact factor: 44.544
Authors: Tara Clinton-McHarg; Mariko Carey; Rob Sanson-Fisher; Anthony Shakeshaft; Kathy Rainbird Journal: Health Qual Life Outcomes Date: 2010-03-06 Impact factor: 3.186
Authors: Tyler W Buckner; Jichuan Wang; Darren A DeWalt; Shana Jacobs; Bryce B Reeve; Pamela S Hinds Journal: Pediatr Blood Cancer Date: 2014-03-15 Impact factor: 3.167
Authors: Helen M Parsons; Linda C Harlan; Charles F Lynch; Ann S Hamilton; Xiao-Cheng Wu; Ikuko Kato; Stephen M Schwartz; Ashley W Smith; Gretchen Keel; Theresa H M Keegan Journal: J Clin Oncol Date: 2012-05-21 Impact factor: 44.544
Authors: Megan E Pailler; Lynda K Beaupin; Erin Brewer-Spritzer; Pei C Grant; Rachel M Depner; Kathryn Levy; Kelly E Tenzek Journal: J Adolesc Young Adult Oncol Date: 2020-04-07 Impact factor: 2.223
Authors: Raheem J Paxton; Lee W Jones; Philip M Rosoff; Melanie Bonner; Joann L Ater; Wendy Demark-Wahnefried Journal: Psychooncology Date: 2010-09 Impact factor: 3.894